Protective immune studies against fungi

Year 2020, Volume: 4 Issue: 3, 96 - 101, 30.12.2020

Aikerim Kumondorova Kemal Metiner

https://doi.org/10.30704/http-www-jivs-net.778761

Cited By: 1

Abstract

The immune system is the host's defence against different agents and infections. Understanding the complex and highly dynamic interactions between fungi and host cells in a tissue-specific manner is crucial to facilitate the development of new therapeutic approaches to infections. Generally fungal pathogens rarely cause diseases in immunologically competent individuals. However, commensal and non-pathogenic environmental fungi can cause life-threatening infections in individuals with immune deficiency. Understanding the molecular and cellular bases of immunity to fungi has progressed significantly over the past few years. Despite close interactions with fungi today, how the immune system protects humans and animals from fungal pathogens has not been fully elucidated compared to the immune response to bacteria or viruses. The immune system is the host's defence against various foreign proteins and infections. Understanding the complex and highly dynamic interactions between fungi and host cells is crucial for the development of new therapeutic approaches to infections. Researchers from 15 countries in Europe, Asia, Australia, North and South America have provided the last five years review and original research articles that consist of a wide range of fungal pathogens, disease, effector, regulatory cells and molecular pathways of host immune responses to fungal exposure. In this review, we summarize an outline of the recent findings, perspectives, and reviews about the complex and highly dynamic interactions between fungi and host cells and a contemporary understanding of protective immunity against fungi. This review will allow an overview of the most exciting recent advances in antifungal immunity, discoveries that will help pave the way for the development of new strategies that are seriously needed to combat these devastating diseases.

Keywords

Adaptive Immunity, innate immunity, immunity to fungal

References

• Bongomin, F., Gago, S., Oladele, R. O., & Denning, D. W. (2017). Global and multinational prevalence of fungal diseases-estimate precision. Journal of Fungi (Basel), 3:E57.
• Campos, J. H., Soares, R. P., Ribeiro, K., Andrade, A.C., Batista, W. L., & Torrecilhas, A. C. (2015). Extracellular vesicles: role in inflammatory responses and potential uses in vaccination in cancer and infectious diseases. Journal of Immunology Research, 2015:832057.
• Freitas, M. S., Bonato, V. L. D., Pessoni, A. M., Rodrigues, M.L., Casadevall, A., & Almeifa, F. (2019). Fungal extracellular vesicles as potential targets for immune interventions. Journal of Clinical Mycrobiology (M Sphere), 4:e00747-19.
• Fisher, M. C., Hawkins, N. J., Sanglard, D., & Gurr, S. J. (2018). Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science, 360, 739–42.
• Erwig, L. P., & Gow, N. A. (2016). Interactions of fungal pathogens with phagocytes. Nature Reviews Microbiology,14(3),163–176.
• Garfoot, A. L., Shen, Q., WXthrich, M., Klein, B. S., & Rappleye, C. A. (2016). The Eng1 β-glucanase enhances histoplasma virulence by reducing β-glucan exposure. American Society for Microbiology, MBio; 7(2):e01388–e01315.
• Huang, H., Ostroff, G. R., Lee, C. K., Specht, C. A., & Levitz, S. M. (2010). Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio, 1(3):e00164.
• Khanna, N., Stuehler, C., Lünemann, A., Agnieszka, W., Pierre-Yves B., & LeibundGut-Landmann, S. (2016). Host response to fungal infections-how immunology and host genetics could help to identify and treat patients at risk. Swiss Medical Weekly, 21, 146:w14350.
• Kumar, V., van de Veerdonk, F.L., & Netea, M. G. (2018). Antifungal immune responses: emerging host–pathogen interactions and translational implications. Genome Medicine, 10:39. LeibundGut-Landmann, S., Wüthrich, M., & Hohl, T. M. (2012). Immunity to Fungi. Current opinion in immunology, 24(4), 449-458.
• Leonardi, I., Li, X., Semon, A., Li, D., Doron, I., Putzel, G., Bar, A., Rescigno, M., McGovern, D. P. B., Pla, J., & Iliev, D. I. (2018). CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. Science. 359, 232–236.
• Lionakis, M. S., Iliev, I. D., & Hohl, T. M. (2017). Immunity against fungi. Journal of clinical investigation insight, 2(11):e93156.
• Mukaremera, L., Lee, K. K., Mora-Montes, H. M., & Gow, N. A. R. (2017). Candida albicans yeast, pseudohyphal, and hyphal morphogenesis differentially affects Immune recognition. Front Immunol, 7, 8:629.
• Nanjappa, S. G., Heninger, E., Wüthrich, M., Sullivan, T., & Klein, B. (2012). Protective antifungal memory CD8+ T cells are maintained in the absence of CD4+ T cell help and cognate antigen in mice. Journal of Clinical Investigation, 122, 987-999.
• Romani, L. (2008). Cell mediated immunity to fungi: a reassessment. Medical Mycology, 46(6), 515-529.
• Romani, L. (2011). Immunity to fungal infections. Nature Reviews Immunology, 11, 275-288.
• Jiang, S. (2016). Immunity against fungal infections. Immunology and immunogenetics insights, 8, 3-6.
• Hohl, T. M., Rivera, A., & Pamer, E. G. (2006). Immunity to fungi. Current Opinion in Immunology, 18(4), 465-472.
• Templeton, S. P., Rivera, A., Hube, B., & Jacobsen, I. D. (2018). Immunity to Human Fungal Pathogens: Mechanisms of host recognition, protection, pathology, and fungal interference. Frontiers in Immunology. 9:2337.
• Uehling, J., Deveau, A., & Paoletti, M. (2017). Do fungi have an innate immune response? An NLR-based comparison to plant and animal immune systems. PLoS Pathogens, 13(10): e1006578.
• Ural, K., & Ulutas. B. (2008). Immunization with Trichophyton verrucosum vaccine in hunter/Jumper and dressage horses with naturally occurring Trichophyton equinum infection: A Prospective, randomized, double-blinded, placebo-controlled clinical trial. Journal of Equine Veterinary Science, 28(10),590-593.
• Westhoff, D. K., Kloes, M. C., Orveillon, F. X., Farnow, D., Elbers, K., & Mueller, R. C. (2010). Treatment of feline dermatophytosis with an inactivated fungal vaccine. The Open Mycology Journal, 4, 10-17.
• Wüthrich, M., Hung, C. Y., Gern, B. H., Pick-Jacobs, J. C., Galles, K. J., Filutowicz, H. I., Cole, G. T., & Klein, B. S. (2011). A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. Journal of Immunology, 187, 1421-1431.
• Wüthrich, M., Gern, B., Hung, C. Y., Ersland, K., Rocco, N., Pick-Jacobs, J., Galles, K., Filutowicz, H., Warner, T., Evans M., Cole, G., & Klein, B. (2011). Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. Journal of Clinical Investigation, 121, 554-568.